208 related articles for article (PubMed ID: 26379164)
1. Reduced All-cause Child Mortality After General Measles Vaccination Campaign in Rural Guinea-Bissau.
Fisker AB; Rodrigues A; Martins C; Ravn H; Byberg S; Thysen S; Storgaard L; Pedersen M; Fernandes M; Benn CS; Aaby P
Pediatr Infect Dis J; 2015 Dec; 34(12):1369-76. PubMed ID: 26379164
[TBL] [Abstract][Full Text] [Related]
2. Research protocol of two concurrent cluster-randomized trials: Real-life Effect of a CAMPaign with Measles Vaccination (RECAMP-MV) and Real-life Effect of a CAMPaign with Oral Polio Vaccination (RECAMP-OPV) on mortality and morbidity among children in rural Guinea-Bissau.
Varma A; Jensen AKG; Thysen SM; Pedersen LM; Aaby P; Fisker AB
BMC Public Health; 2019 Nov; 19(1):1506. PubMed ID: 31711464
[TBL] [Abstract][Full Text] [Related]
3. A general measles vaccination campaign in urban Guinea-Bissau: Comparing child mortality among participants and non-participants.
Byberg S; Thysen SM; Rodrigues A; Martins C; Cabral C; Careme M; Aaby P; Benn CS; Fisker AB
Vaccine; 2017 Jan; 35(1):33-39. PubMed ID: 27890397
[TBL] [Abstract][Full Text] [Related]
4. Co-administration of live measles and yellow fever vaccines and inactivated pentavalent vaccines is associated with increased mortality compared with measles and yellow fever vaccines only. An observational study from Guinea-Bissau.
Fisker AB; Ravn H; Rodrigues A; Østergaard MD; Bale C; Benn CS; Aaby P
Vaccine; 2014 Jan; 32(5):598-605. PubMed ID: 24325827
[TBL] [Abstract][Full Text] [Related]
5. Is early measles vaccination associated with stronger survival benefits than later measles vaccination?
Hansen JS; Thysen SM; Rodrigues A; Martins C; Fisker AB
BMC Public Health; 2018 Aug; 18(1):984. PubMed ID: 30086732
[TBL] [Abstract][Full Text] [Related]
6. Contrasting female-male mortality ratios after routine vaccinations with pentavalent vaccine versus measles and yellow fever vaccine. A cohort study from urban Guinea-Bissau.
Fisker AB; Biering-Sørensen S; Lund N; Djana Q; Rodrigues A; Martins CL; Benn CS
Vaccine; 2016 Aug; 34(38):4551-4557. PubMed ID: 27475473
[TBL] [Abstract][Full Text] [Related]
7. Reduced childhood mortality after standard measles vaccination at 4-8 months compared with 9-11 months of age.
Aaby P; Andersen M; Sodemann M; Jakobsen M; Gomes J; Fernandes M
BMJ; 1993 Nov; 307(6915):1308-11. PubMed ID: 8257884
[TBL] [Abstract][Full Text] [Related]
8. A Two-Center Randomized Trial of an Additional Early Dose of Measles Vaccine: Effects on Mortality and Measles Antibody Levels.
Fisker AB; Nebie E; Schoeps A; Martins C; Rodrigues A; Zakane A; Kagone M; Byberg S; Thysen SM; Tiendrebeogo J; Coulibaly B; Sankoh O; Becher H; Whittle HC; van der Klis FRM; Benn CS; Sie A; Müller O; Aaby P
Clin Infect Dis; 2018 May; 66(10):1573-1580. PubMed ID: 29177407
[TBL] [Abstract][Full Text] [Related]
9. Out-of-sequence DTP and measles vaccinations and child mortality in Guinea-Bissau: a reanalysis.
Thysen SM; Rodrigues A; Aaby P; Fisker AB
BMJ Open; 2019 Sep; 9(9):e024893. PubMed ID: 31492774
[TBL] [Abstract][Full Text] [Related]
10. Overall effect of a campaign with measles vaccine on the composite outcome mortality or hospital admission: A cluster-randomized trial among children aged 9-59 months in rural Guinea-Bissau.
Varma A; Thysen SM; Martins JSD; Nanque LM; Jensen AKG; Fisker AB
Int J Infect Dis; 2023 Sep; 134():23-30. PubMed ID: 37182547
[TBL] [Abstract][Full Text] [Related]
11. Child mortality following standard, medium or high titre measles immunization in West Africa.
Knudsen KM; Aaby P; Whittle H; Rowe M; Samb B; Simondon F; Sterne J; Fine P
Int J Epidemiol; 1996 Jun; 25(3):665-73. PubMed ID: 8671571
[TBL] [Abstract][Full Text] [Related]
12. Effects of the introduction of new vaccines in Guinea-Bissau on vaccine coverage, vaccine timeliness, and child survival: an observational study.
Fisker AB; Hornshøj L; Rodrigues A; Balde I; Fernandes M; Benn CS; Aaby P
Lancet Glob Health; 2014 Aug; 2(8):e478-87. PubMed ID: 25103521
[TBL] [Abstract][Full Text] [Related]
13. Does oral polio vaccine have non-specific effects on all-cause mortality? Natural experiments within a randomised controlled trial of early measles vaccine.
Aaby P; Andersen A; Martins CL; Fisker AB; Rodrigues A; Whittle HC; Benn CS
BMJ Open; 2016 Dec; 6(12):e013335. PubMed ID: 28011813
[TBL] [Abstract][Full Text] [Related]
14. Survival of previously measles-vaccinated and measles-unvaccinated children in an emergency situation: an unplanned study.
Aaby P; Garly ML; Balé C; Martins C; Jensen H; Lisse I; Whittle H
Pediatr Infect Dis J; 2003 Sep; 22(9):798-805. PubMed ID: 14506371
[TBL] [Abstract][Full Text] [Related]
15. Sex differences in the effect of vaccines on the risk of hospitalization due to measles in Guinea-bissau.
Aaby P; Martins C; Bale C; Garly ML; Rodrigues A; Biai S; Lisse IM; Whittle H; Benn CS
Pediatr Infect Dis J; 2010 Apr; 29(4):324-8. PubMed ID: 19934785
[TBL] [Abstract][Full Text] [Related]
16. Analysis of risk factors for infant mortality in the 1992-3 and 2002-3 birth cohorts in rural Guinea-Bissau.
Byberg S; Østergaard MD; Rodrigues A; Martins C; Benn CS; Aaby P; Fisker AB
PLoS One; 2017; 12(5):e0177984. PubMed ID: 28542646
[TBL] [Abstract][Full Text] [Related]
17. DTP with or after measles vaccination is associated with increased in-hospital mortality in Guinea-Bissau.
Aaby P; Biai S; Veirum JE; Sodemann M; Lisse I; Garly ML; Ravn H; Benn CS; Rodrigues A
Vaccine; 2007 Jan; 25(7):1265-9. PubMed ID: 17092614
[TBL] [Abstract][Full Text] [Related]
18. Cost-effectiveness of providing measles vaccination to all children in Guinea-Bissau.
Byberg S; Fisker AB; Thysen SM; Rodrigues A; Enemark U; Aaby P; Benn CS; Griffiths UK
Glob Health Action; 2017; 10(1):1329968. PubMed ID: 28580855
[TBL] [Abstract][Full Text] [Related]
19. Effect of an Early Dose of Measles Vaccine on Morbidity Between 18 Weeks and 9 Months of Age: A Randomized, Controlled Trial in Guinea-Bissau.
Do VA; Biering-Sørensen S; Fisker AB; Balé C; Rasmussen SM; Christensen LD; Jensen KJ; Martins C; Aaby P; Benn CS
J Infect Dis; 2017 Apr; 215(8):1188-1196. PubMed ID: 28077730
[TBL] [Abstract][Full Text] [Related]
20. The effect of early measles vaccination at 4.5 months of age on growth at 9 and 24 months of age in a randomized trial in Guinea-Bissau.
Rasmussen SM; Biering-Sørensen S; Byberg S; Andersen A; Bjerregaard-Andersen M; Rodrigues A; Benn CS; Martins CL; Aaby P
BMC Pediatr; 2016 Dec; 16(1):199. PubMed ID: 27912735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
